Cigna Retains Formulary Management Control Under Contract With PBM Catamaran
This article was originally published in The Pink Sheet Daily
Executive Summary
Under the 10-year contract, Catamaran will bring its “leading technology and service platform” to enhance operations of Cigna’s internal PBM. The deal is also expected to bolster Cigna’s drug purchasing power and help lower costs.
You may also be interested in...
Express Scripts Combination With Cigna's PBM Could Reverse Deficit From Losing Anthem
Merger could restore number of covered lives PBM will lose once its contract with Anthem expires, but there is also risk of alienating current health plan clients who don't want to contract with a competitor.
Deal Watch: Teva Boosts CNS Portfolio With $3.2 Billion Purchase Of Auspex
Novartis raises its game in immuno-oncology through Aduro collaboration, while Merck Serono partners up with a CAR-T program at Intrexon. UnitedHealth grows its PBM business by acquiring Catamaran; Horizon expands its orphan drug portfolio in buyout of Hyperion.
OptumRx To Be ‘Competitive Force’ In PBM Industry With Catamaran Buy
The merger of UnitedHealth Group’s pharmacy benefit manager OptumRx with Catamaran could give the combined firm greater pricing leverage as it becomes one of the industry's giants, along with CVS Health’s Caremark and Express Scripts.